These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30117390)

  • 41. Molecular basis of ethnic differences in drug disposition and response.
    Xie HG; Kim RB; Wood AJ; Stein CM
    Annu Rev Pharmacol Toxicol; 2001; 41():815-50. PubMed ID: 11264478
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human drug metabolizing cytochromes P450.
    Wrighton SA; VandenBranden M; Ring BJ
    J Pharmacokinet Biopharm; 1996 Oct; 24(5):461-73. PubMed ID: 9131485
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs.
    Ghersi-Egea JF; Leninger-Muller B; Suleman G; Siest G; Minn A
    J Neurochem; 1994 Mar; 62(3):1089-96. PubMed ID: 8113796
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differences in Toxicological and Pharmacological Responses Mediated by Polymorphic Cytochromes P450 and Related Drug-Metabolizing Enzymes.
    Yamazaki H
    Chem Res Toxicol; 2017 Jan; 30(1):53-60. PubMed ID: 27750412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human cytochrome P450: possible roles of drug-metabolizing enzymes and polymorphic drug oxidation in addiction.
    Gonzalez FJ
    NIDA Res Monogr; 1991; 111():202-13. PubMed ID: 1775182
    [No Abstract]   [Full Text] [Related]  

  • 46. The cytochrome p-450 drug metabolizing enzyme system: an overview of potential clinically important drug interactions.
    Wroblewski B; Glenn MB
    J Head Trauma Rehabil; 2002 Dec; 17(6):571-4. PubMed ID: 12802247
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of vitamin A deficiency on hepatic and intestinal drug metabolizing enzymes in rats.
    Gupta PH; Mehta S; Mehta SK
    Biochem Int; 1989 Jul; 19(1):123-33. PubMed ID: 2505773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Advances in understanding drug metabolism and its contribution to variability in patient response.
    Tucker GT
    Ther Drug Monit; 2000 Feb; 22(1):110-3. PubMed ID: 10688271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacogenomics in Critical Care.
    Cheek D; Howington L
    AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of liver disease on inhibitory and plasma protein-binding displacement interactions: an update.
    Palatini P; Orlando R; De Martin S
    Expert Opin Drug Metab Toxicol; 2010 Oct; 6(10):1215-30. PubMed ID: 20604736
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward Computational Understanding of Molecular Recognition in the Human Metabolizing Cytochrome P450s.
    Kontoyianni M; Lacy B
    Curr Med Chem; 2018; 25(28):3353-3373. PubMed ID: 29484977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic polymorphisms in drug-metabolizing enzymes and drug targets.
    Hiratsuka M; Mizugaki M
    Mol Genet Metab; 2001 Aug; 73(4):298-305. PubMed ID: 11509011
    [No Abstract]   [Full Text] [Related]  

  • 53. Potential drug interactions associated with glycyrrhizin and glycyrrhetinic acid.
    Feng X; Ding L; Qiu F
    Drug Metab Rev; 2015 May; 47(2):229-38. PubMed ID: 25825801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacoepigenetics: its role in interindividual differences in drug response.
    Gomez A; Ingelman-Sundberg M
    Clin Pharmacol Ther; 2009 Apr; 85(4):426-30. PubMed ID: 19242404
    [No Abstract]   [Full Text] [Related]  

  • 55. Characterization of human cytochrome P450 enzymes.
    Guengerich FP
    FASEB J; 1992 Jan; 6(2):745-8. PubMed ID: 1537465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
    Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
    AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of metabolic enzymes by dietary phytochemicals: a review of mechanisms underlying beneficial versus unfavorable effects.
    Mandlekar S; Hong JL; Kong AN
    Curr Drug Metab; 2006 Aug; 7(6):661-75. PubMed ID: 16918318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantitative profiling of the UGT transcriptome in human drug-metabolizing tissues.
    Tourancheau A; Rouleau M; Guauque-Olarte S; Villeneuve L; Gilbert I; Droit A; Guillemette C
    Pharmacogenomics J; 2018 Apr; 18(2):251-261. PubMed ID: 28440341
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug-metabolizing enzymes in the skin of man, rat, and pig.
    Oesch F; Fabian E; Oesch-Bartlomowicz B; Werner C; Landsiedel R
    Drug Metab Rev; 2007; 39(4):659-98. PubMed ID: 18058329
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.